Vimarsana
Biggest News Aggregation in the World

Page 3 - Clinical Reader News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Clinical Reader. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Clinical Reader Today - Breaking & Trending Today

SC-Elastrin Therapeutics Inc.: Elastrin Therapeutics Announces Newly Formed Scientific Advisory Board - Vimarsana News

SC-Elastrin Therapeutics Inc.: Elastrin Therapeutics Announces Newly Formed Scientific Advisory Board

Elastrin Therapeutics Inc., a privately held biotechnology company leveraging a platform technology to develop therapeutics that render calcified tissue and organs supple again, announced the formation

Human challenge models to advance vaccines against respiratory pathogens - Vimarsana News

Human challenge models to advance vaccines against respiratory pathogens

Human challenge models to advance vaccines against respiratory pathogens World Immunisation Week 2021 To mark World Immunisation Week 2021 from 24 to 30 April, the London School of Hygiene & Tropical Medicine (LSHTM) Vaccine Centre is hosting a series of webinars. The theme this year is ‘Vaccines Bring Us Closer’. Each day of the week we focus on an important area of vaccine research, science and debate bringing together experts in the field. We end the week with the Vaccine Centre Annual Lecture on 30 April.  In this event, we focus on the use of controlled h...

Ethics Approval Granted for Open Orphan's COVID-19 Human Challenge Study Model - Vimarsana News

Ethics Approval Granted for Open Orphan's COVID-19 Human Challenge Study Model

Press release content from Business Wire. The AP news staff was not involved in its creation. Ethics Approval Granted for Open Orphan’s COVID-19 Human Challenge Study Model February 17, 2021 GMT LONDON--(BUSINESS WIRE)--Feb 17, 2021-- Open Orphan plc (AIM: ORPH), a rapidly growing specialist pharmaceutical services clinical research organisation (CRO) and world leader in vaccine and antiviral testing using human challenge clinical trials, announces the world’s first COVID-19 characterization study has received approval from a specially convened Research Ethics Committee (REC). This news f...

Source: apnews.com
Investegate |Open Orphan PLC Announcements | Open Orphan PLC: Ethics approval - Vimarsana News

Investegate |Open Orphan PLC Announcements | Open Orphan PLC: Ethics approval

  Open Orphan plc (London and Euronext: ORPH) is a rapidly growing pharmaceutical service/contract research company that is a world leader in testing vaccines and antivirals using human challenge clinical trials. The company provides services to Big Pharma, biotech and government/public health organisations.   Open Orphan runs challenge studies in London from both its 19-bedroom Whitechapel quarantine clinic, opened in February 2021, and its 24-bedroom QMB clinic which also has a highly specialised virology and immunology laboratory on-site. Open Orphan has a leading portfolio of eight huma...

Researchers suggest ways to cope with long term Covid-19 symptoms - Vimarsana News

Researchers suggest ways to cope with long term Covid-19 symptoms

Researchers suggest ways to cope with long term Covid-19 symptoms February 11, 2021 × The study, published in the Oxford Open Immunology by Oxford University Press, stated that although Covid-19 was initially believed to be a short-term illness, a substantial number of patients experience symptoms beyond that A new study carried out by researchers at the King’s College London suggested some potential treatment strategies for patients suffering from Covid-19 long haul. The study, published in the Oxford Open Immunology by Oxford University Press, stated that although Covid-19 was initially ...